Member Info for bignose58

Irrespective of Fortacin sales, Recordati still appear to be doing quite well. Just announced their divi of 1 euro/share . Up 8.7 % on last year. Unfortunately we cannot say the same. I wonder why that is? Could it have something to do with an incompetent management.... ;-)

Well obviously someone didn't like to use of "Vinegar stroke". Surprising since the product is for just that or rather to prevent it.

As I wrote. With the Covid-19 lockdown and people having to stay at home getting bored, only allowed out to shop for food and visit the doctors, will this encourage more sufferers to get out and visit the doctors for preventative measures and reduce additional distress at home ???

If you can’t handle the heat, get outta the kitchen. Pity RPG isn’t actually called hygena..... lol

In case anyone missed it.

There was a UK filing on 17th March stating JG had relocated to Scotland from South Africa....... No reason given as to why, but maybe he is just moving back to his roots. Don't suppose it changes his tax situation.

https://beta.companieshouse.gov.uk/company/04977609/filing-history

Then is definitely has to be correct..........Errr not....lol

Botwell,
Interesting stuff, however. I’m pretty sure Dr Mike’s salary is nowhere near as high as you state (maybe you can indicate where this information came from since I cannot find any ref to it) and given the recent announcements, isn’t Jamie’s holding higher or is this only after another 3 years, if the company is still solvent..... :-O

I was just about to write. Some really odd goings on with the price action at the moment. Certainly makes no sense. Not only was the last sale only for 10k shares, but as you pointed out, it too the sp up 2+%, which, given it was a "Other" transaction (non automatic matching) that are usually below the opening price, make it weird. (see the first "Other" of the day at 0.069). it then opened over 7% down on 30k shares (about 20 squidaroonies). Jiggery pokery at its best n'est'pa.

Thanks The.Italian, but just writing it the way it is.

JM may still be very excited about the future prospects, like he was about the EU launch ("disappointed we didn't make a profit" - even though the company needed +28mill just to break even with the PLE write down)... remember that one. If he really wants to be sure of the money fountain in the US, he should request JG sub an online study (like the German one) to see if anyone would buy the product, which, based on our recent discussion, is looking more and more ominous. I think the jury are still out on that one...LOL

Apols for posting twice....... Really not sure what happened there... I guess better twice than not at all. ;-)

Thanks for that Heimdal.

Hope things are ok for you in HK with the current situation ?

I don't think anyone is freaking out, as you put it. We just have a concern that in JG's tenure as CEO of the joint company, we have witnessed its market cap dropping 90%, which surely is a concern in anybody's book ?

Although I am sure you are right with respect to Jim keeping the lights on, one also has to remember his recent exploits with other companies which have left pi's with empty pockets. I am referring to LIFE and PEBI, not forgetting the DBC. His + 31% holding is not that significant for him as its just a mosquito bite on his vast fortune (about 900mill GBP last time I looked), so one needs to keep a little bit of perspective as to ones hobbies and those that actually invest. JG's salary is now running at 8% of the current market Cap (it was nearly 10% a couple of days ago). If JM was that good a business man, he would do something about this fact. Just think; If JG had only been paid half of his current salary, which would still be too much, the company would have had 4.5mill USD in the bank. Instead JG gets to loan the company nearly that at approx. 12% interest (compounded over 3 years, but taken up front). That's of course if the company ever gets back to 0.215HK being the placing price.

As to the HK listing value, which I understand from JM as being about 40mill USD; I am sure no one cares about that valuation till a company is sold (otherwise we would never be lower than that). The final agreed price will probably just be adjusted to absorb it.

The Yooya deal may have come out of left field, but what happened to the "more concrete" one down the middle? Nothing more about that, yet more importance was put on it when included in the announcement, otherwise why use the term concrete ? It was included just to try and deflect, nothing more than utter lies otherwise the company would have been far more upfront with the information as to who it was and what happened........no ?

All my own opinion of course. And as usual. I am still supportive of the product, but have nothing but contempt for the amateur's who are running the company (Phase II end of march 2020, then end of 2019, now Q4 2020..... if that ever happens and that's after an "unambiguous FDA agreement on a way forward in March 2014").

Thanks for that Heimdal.

Hope things are ok for you in HK with the current situation ?

I don't think anyone is freaking out, as you put it. We just have a concern that in JG's tenure as CEO of the joint company, we have witnessed its market cap dropping 90%, which surely is a concern in anybody's book ?

Although I am sure you are right with respect to Jim keeping the lights on, one also has to remember his recent exploits with other companies which have left pi's with empty pockets. I am referring to LIFE and PEBI, not forgetting the DBC. His + 31% holding is not that significant for him as its just a mosquito bite on his vast fortune (about 900mill GBP last time I looked), so one needs to keep a little bit of perspective as to ones hobbies and those that actually invest. JG's salary is now running at 8% of the current market Cap (it was nearly 10% a couple of days ago). If JM was that good a business man, he would do something about this fact. Just think; If JG had only been paid half of his current salary, which would still be too much, the company would have had 4.5mill USD in the bank. Instead JG gets to loan the company nearly that at approx. 12% interest (compounded over 3 years, but taken up front). That's of course if the company ever gets back to 0.215HK being the placing price.

As to the HK listing value, which I understand from JM as being about 40mill USD; I am sure no one cares about that valuation till a company is sold (otherwise we would never be lower than that). The final agreed price will probably just be adjusted to absorb it.

The Yooya deal may have come out of left field, but what happened to the "more concrete" one down the middle? Nothing more about that, yet more importance was put on it when included in the announcement, otherwise why use the term concrete ? It was included just to try and deflect, nothing more than utter lies otherwise the company would have been far more upfront with the information as to who it was and what happened........no ?

All my own opinion of course. And as usual. I am still supportive of the product, but have nothing but contempt for the amateur's who are running the company (Phase II end of march 2020, then end of 2019, now Q4 2020..... if that ever happens and that's after an "unambiguous FDA agreement on a way forward in March 2014").

The Italian,

I thought the valuation issue was on our side (making a low offer) given the announcement made by FFWD about taking a hit?

Unf not, but I see they are up about 17 times since Jan. Still, you have done quite well in the short time you have been in. ;-)

Probably, but there also was no mention of the other more concrete alternative....... just BS

I would not be surprised if JM hasn't got one of his minions to purchase on his behalf (nudge, nudge, wink, wink) a few shares just to lift it ???

Are we seeing a small P & D as I cannot see why investors would want to invest now given the really bad results announcement and its return to high risk ??? Thoughts ....anyone......anyone...... mmm they all must have gotten out the pool ..LOL

The.Italian,

Certainly no need to apologise, as it’s open season where stocks are concerned. Especially these days where stocks like FUM have fallen a lot (100mill peak). Of course they have had a major failure which caused most of the drop, but it certainly reads like they will come back hugely, even if only to double the 100mill, which is easily doable. Good luck is what I say.

The.Italian,

I see you may be thinking of moving over to the dark side (ED) Or you may have already started moving ... ;-)

I too have been watching FUM from a distance for many months.

Since the ED market is already established and a known entity, I am sure FUM will do ok. The billions in income from the few can be quite easily distributed to the many....like FUM.

I think its going to be quite sometime before the PE market is prepared to get over the "embarrassment" factor. As such, the idea that once approved, Fortacin will be the companies bread n butter will probably not happen, hence there being no license agreements in place. Any proposals will be only in pounds, shillings and pence rather than the millions optimistically expected. I mean the China license has only come about since 2017 (maybe even later) whereas the US License discussions have been since the beginning of 2014 and evolved in to zilch.

Bothwell,

He hasn't got it moving in the last 4 years, what makes you feel he can do it now ?

Well, I am surprised to see a 3% rise today after the shocking news last evening.

This would indicate to me:
1. The news was already leaked several weeks ago, hence the drop to where we are now (and probably not so much to do with the C-19).

2. The investors buying are only traders who have no ide what the company does or had reported yesterday.

Maybe given time, there will commence a huge sell off in the next week or two ?

I still find it hard to believe the misinformation we are constantly given related to the FDA approval process its quite incredibly for a 1.5mill salary (now standing at nearly 10% of the companies worth),,,keerrrcchhhiinggg thankyou very much.